GLP-1 drug side effects stories

Oct 7, 2026

WHO recommends against obesity drugs for children under 10

The World Health Organization issued its first global guidelines on childhood obesity, strongly recommending against GLP-1 weight-loss medications for children under age 10, citing unclear long-term effects. The guidance prioritizes diet, exercise and counseling instead.

Oct 7, 20263 sources

Oct 6, 2026

European regulators raise concerns about eye stroke risk with GLP-1 drugs

European regulators have raised concerns about nonarteritic anterior ischemic optic neuropathy (NAION), sometimes called an "eye stroke," as a very rare potential side effect of GLP-1 medications like semaglutide and tirzepatide. Studies have shown patients with type 2 diabetes on these drugs have a small increased incidence of the eye disorder.

Oct 6, 20262 sources